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Abstract
Background: Past evidence has suggested a role of artificial sweeteners in allergic disease; yet, the evidence has been
inconsistent and unclear.
Objective: To examine relation of intake of artificially-sweetened beverages during pregnancy with child asthma and
allergic rhinitis at 18 months and 7 years.
Methods:We analyzed data from 60,466 women enrolled during pregnancy in the prospective longitudinal Danish National
Birth Cohort between 1996 and 2003. At the 25th week of gestation we administered a validated Food Frequency
Questionnaire which asked in detail about intake of artificially-sweetened soft drinks. At 18 months, we evaluated child
asthma using interview data. We also assessed asthma and allergic rhinitis through a questionnaire at age 7 and by using
national registries. Current asthma was defined as self-reported asthma diagnosis and wheeze in the past 12 months. We
examined the relation between intake of artificially-sweetened soft drinks and child allergic disease outcomes and present
here odds ratios with 95% CI comparing daily vs. no intake.
Results: At 18 months, we found that mothers who consumed more artificially-sweetened non-carbonated soft drinks were
1.23 (95% CI: 1.13, 1.33) times more likely to report a child asthma diagnosis compared to non-consumers. Similar results
were found for child wheeze. Consumers of artificially-sweetened carbonated drinks were more likely to have a child asthma
diagnosis in the patient (1.30, 95% CI: 1.01, 1.66) and medication (1.13, 95% CI: 0.98, 1.29) registry, as well as self-reported
allergic rhinitis (1.31, 95% CI: 0.98, 1.74) during the first 7 years of follow-up. We found no associations for sugar-sweetened
soft drinks.
Conclusion: Carbonated artificially-sweetened soft drinks were associated with registry-based asthma and self-reported
allergic rhinitis, while early childhood outcomes were related to non-carbonated soft drinks. These results suggest that
consumption of artificially-sweetened soft drinks during pregnancy may play a role in offspring allergic disease
development.
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Introduction
It has been hypothesized that diet during pregnancy may
modulate child immune system development and later allergic
disease. Past studies have examined numerous dietary factors
during pregnancy, including fruits and vegetables [1–6], fish [1–
5,7–12] and fish oil [13], butter and margarine [2,3,5,7], nut and
peanuts [2,4,14], and dairy and milk intake [2–5,14,15] in relation
to allergic disease in the child. We recently conducted an analysis
of the relation between milk and yoghurt consumption during
pregnancy and wheeze, asthma, and allergic rhinitis in the Danish
National Birth Cohort (DNBC) [16]. We found that the strongest
and most consistent association was between maternal low-fat
yoghurt intake and child asthma and allergic rhinitis. These results
suggested a causal agent specific to low-fat yoghurt. We
hypothesized that artificial sweeteners could be a plausible
candidate as these compounds are often added to low-fat/’light’
products to compensate for flavour or reduce sugar content [17].
The current state of knowledge on the role of artificial sweeteners
in allergic disease development is at best limited. A few studies
have examined aspartame in relation to inflammation; yet, these
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results have been inconsistent [18–20]. A study from the 1980s
[21] examined in vitro immunological properties and found small
inhibitory effects on antigen-induced histamine release from
cultured mouse mast cells. However, the authors could not
explain the origin or meaning of this effect. Other studies have
shown improvements in dermatitis with aspartame avoidance
[22,23], while yet others found no elicit allergic reactions [24,25].
This suggests that improvement in dermatitis is most likely a
relatively rare side effect of aspartame avoidance. To our
knowledge, there are no epidemiological studies assessing the
relation between intake of artificial sweeteners during pregnancy
and asthma or other allergic diseases.
We therefore decided to examine whether artificially-sweetened
soft drinks during pregnancy modify offspring risk of wheeze,
asthma, and allergic rhinitis in the DNBC. We chose soft drink as
the exposure because these have been identified as a primary
source of artificial sweeteners [26]. We included intake of sugar-
sweetened beverages as a control for potential activity of other
nutritional components and additives in soft drinks [26].
Methods
Ethics Statement
Mothers provided written informed consent on behalf of their
children. The Regional Scientific Ethics Committee for the
municipalities of Copenhagen and Frederiksberg approved all
study protocols, and all procedures were in accordance with the
Declaration of Helsinki.
Population and Study Design
Participants in the DNBC, a large prospective cohort study,
were enrolled between January 1996 and October 2002 during
their first antenatal visit between weeks 6 and 10 of gestation [27].
All women living in Denmark were eligible if they could speak
Danish and were planning to carry to term. About 60% of all
eligible women received an invitation from their general practi-
tioner; of those 60% chose to enrol. Women participated in four
telephone interviews, twice during pregnancy and twice postpar-
tum, at 6 and 18 months. They also filled out a food frequency
questionnaire (FFQ) around the 25th week of gestation. We have
followed the mother-child pairs through national registries, linked
by the unique identity number given to all Danish citizens. A
questionnaire regarding the child was sent to the mothers when
the child was 7 years.
A total of 101,045 pregnancies were enrolled into the study. To
avoid dependency among correlated observations, we included
only the first liveborn singleton child enrolled for each woman
(n = 89,333). We further excluded multiple births (n = 87,056).
After eliminating women with missing exposure data, 60,466
women had information on artificially-sweetened carbonated
beverage consumption.
Exposure Variables
Maternal diet assessment was based on a validated 360-item
semi-quantitative FFQ completed around gestation week 25 and
covered intake during the previous four weeks [28]. Intake of
individual food items were estimated in grams per day based on
standard portion sizes; total energy and nutrients were quantified
using Danish food tables [29]. Women were asked a number of
questions on beverage consumption with response categories
ranging from never to .=8 servings/d. One serving was
equivalent to one glass. We used four beverage items in our
analyses: carbonated soft drinks/cola (sugar sweetened), carbon-
ated soft drinks/cola (sugar-free, light), noncarbonated soft drinks
(sugar sweetened), and noncarbonated soft drinks (sugar-free,
light). The wording of the responses used the words sugar-free and
light to refer to products that contained artificial sweeteners. We
distinguished between carbonated and non-carbonated beverages
as they contain different types of artificial sweeteners [26]. These
beverages were subject to a repeatability study where 103 women
filled in the FFQ twice during pregnancy (in week 25 and 35 of
gestation). For these women the observed Spearman correlation
coefficient for all four types of soft drink consumption was around
0.7 [30].
Outcome Measurements
Asthma at 18 months. Women were telephone interviewed
when the child was 18 months (N,45,000). The women answered
questions about child health and diagnoses since birth. We defined
asthma at 18 months as self-reported doctor asthma diagnosis.
Asthma and allergic rhinitis at 7 years. We evaluated
asthma and allergic rhinitis diagnosis at the 7 year follow-up by
numerous sources. Current asthma at age 7 (N,38,000) by self-report
was defined as a positive response to standardized International
Study of Asthma and Allergies in Childhood questions on doctor-
diagnosed asthma and wheezing symptoms in the past 12 months
[31,32]. Ever allergic rhinitis (N,38,000) by self-report was based on
a reported doctor-diagnosis of hay fever.
We further used data on hospital admissions collected by the
mandatory Danish National Patient Registry (DNPR). Admission
information has been collected since 1977, and emergency room
and outpatient contacts since 1995. The registry has been
validated against asthma diagnosis from hospital records [33].
We extracted data from the DNPR in Aug 2010 and linked it to
our data using the CPR number. We identified ever admitted asthma
(N,38,000) cases using the International Classification of Disease
10 (ICD-10) for asthma (J45, J45.0, J45.1, J45.8, J45.9, J46, and
J46.9).
We also used the Register of Medicinal Product Statistics
(RMPS) that was initiated in 1995 and contains detailed
individual-level dispensary information [34]. Based on a previous
validation study [35] we combined Anatomical Therapeutic
Chemical codes for the classification of ever medication-related asthma
(N,38,000) cases. The outcome was defined as at least two
prescriptions of drugs for obstructive airway disease, except for
beta-2-agonists as liquid, inhaled beta-2-agonists only once, or
inhaled steroid only once.
Both registry outcomes were limited to children with self-
reported data to avoid discordance in findings due to differences in
study populations.
Covariates
We collected information of a number of covariates. These
included socioeconomic status by parental education level and
occupation (SES: high level proficiency, medium level proficiency,
skilled, unskilled, student, unemployment), maternal age at birth of
child (,=20 years, 21–39 years, .=40 years), parity (nulli- and
multiparous), maternal prepregnancy Body Mass Index (BMI in
kg/m2) (,=18.5, 18.6–24.9, 25.0–29.9, 30–34.9, .=35.0),
maternal smoking during pregnancy (nonsmoker, occasional
smoker, current smoker), maternal exercise during pregnancy
(yes/no), gestational weight gain (g/week), breastfeeding duration
(none, 0–1, 2–3, 4–6, 7–9, .=10 months), birth weight (in
grams), gestational age (in days since the last menstrual period),
child sex, maternal and paternal history of asthma and allergies,
and total energy intake. We also examined, in stability analyses,
dietary variables (fruits, vegetables, alcohol, vitamin A, D, E,
selenium, and zinc intake from diet and supplements); and mode
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Table 1. Age-standardized covariate distribution across categories of maternal consumption of artificially-sweetened carbonated
soft drinks during pregnancy, N = 60,465.
Frequency of intake N1 (%)
Never N=40,523%
or means (SD)
,1 serv/week N=7,588%
or means (SD)
Weekly N=9,971%
or means (SD)
.=1 serv/day N=2,383%
or means (SD)
Maternal age (years)*
#20 586 (1) 1 1 1 1
21–39 59,311 (98) 98 98 98 98
$40 567 (1) 1 1 1 1
Prepregnancy BMI (kg/m2)
#18.5 2,476 (4) 5 3 2 2
18.6–24.9 38,212 (68) 71 68 61 54
25.0–29.9 10,885 (19) 18 20 24 27
30.0–34.9 3,299 (6) 5 6 9 11
$35.0 1,219 (2) 2 3 3 5
Physical activity
Yes 22,399 (39) 37 43 41 37
Smoking in pregnancy
Current smokers 7,470 (12) 13 9 10 17
Parity
Nullipara 30,590 (53) 51 58 56 52
Socioeconomic position
High level proficiencies 12,449 (23) 23 23 22 22
Medium level proficiencies 16,692 (31) 30 32 32 30
Skilled 14,601 (27) 26 27 28 29
Unskilled 6,810 (13) 13 12 12 14
Students 2,425 (4) 5 4 4 4
Unemployed 1,462 (3) 3 2 2 2
Breastfeeding duration
No breastfeeding 862 (2) 2 2 2 4
0–1 months 3,988 (9) 9 8 11 13
2–3 months 4,424 (10) 10 9 11 14
4–6 months 8,004 (19) 18 18 20 21
7–9 months 11,636 (27) 27 29 28 22
$10 months 14,078 (33) 34 33 28 26
Maternal asthma
Yes 5,289 (9) 9 9 9 10
Maternal allergies
Yes 18,404 (32) 32 31 32 33
Paternal asthma
Yes 4,720 (8) 8 8 9 9
Paternal allergies
Yes 13,739 (24) 24 24 24 24
Child gender
Male 30,754 (51) 51 52 51 52
Gestational weight gain (g/week) 41,681 468 (213) 465 (211) 465 (223) 460 (241)
Birth weight (g) 57,403 3,572 (571) 3,593 (573) 3,596 (577) 3,595 (588)
Gestational age (days) 60,454 280 (14) 280 (15) 280 (13) 279 (16)
Dietary intake
Energy intake (kJ/day) 60,227 10,208 (2,706) 9,707 (2,570) 9,787 (2,588) 9,945 (2,809)
Fruit intake (g/day) 60,461 320 (267) 327 (270) 329 (258) 335 (327)
Vegetable intake (g/day) 60,461 129 (99) 130 (95) 128 (96) 132 (129)
Alcohol (g/day) 60,227 1.5 (2.3) 1.6 (2.1) 1.7 (2.3) 1.7 (2.8)
Artificial Sweeteners in Pregnancy and Asthma Risk
PLOS ONE | www.plosone.org 3 February 2013 | Volume 8 | Issue 2 | e57261
of delivery (cesarean section, vaginal), pets at home, exposure do
smoking during infancy (no, occasional, yes), daycare attendance
during infancy, and use of antibiotics and paracetamol during
pregnancy and child use of antibiotics (against ear infections) at 6
month.
Statistical Analysis
We evaluated the distribution of covariates across categories of
beverage intake for potential confounding factors. We age-
standardized the distributions using direct standardization as
there was a significant difference in intake across maternal age
categories. Final set of covariates were determined by chi-square
and partial F-tests with a P,0.10 as well as a priori considerations
based on the current literature. We excluded covariates suspected
to be intermediates on the causal pathways, such as birth weight,
gestational age, and gestational weight gain, to avoid over-
adjusting the model. The importance of these variables was instead
assessed using stratification. In the final logistic regression model,
we adjusted for maternal age, smoking, parity, prepregnancy BMI,
physical activity, breastfeeding duration, socio-economic status,
child sex, maternal history of asthma, maternal history of allergies,
paternal history of asthma, paternal history of allergies, and energy
(in quintiles). Soft drinks intake was entered as an indicator
variable and individual exposure categories compared to the
lowest category. We collapsed categories at the higher end due to
scarce data on high-consumers and to increase power. We
therefore ended up with four intake categories (never, ,1serv-
ing/week, weekly (2–6 times/week), .=1serving/day). When
comparing results to the non-collapsed variables, there was a slight
change in effect estimates and confidence intervals, but direction-
ality remained the same. We estimated odds ratios (ORs) and 95%
CI for the final models. Only exposures with strongest and most
consistent results are presented in the main text; the reader is
referred to the Supporting Materials for additional details.
Median values (0, 0.5, 3.5, and 7) for the intake categories were
modelled as a continuous variable to evaluate P-value for trend.
We evaluated the independent associations for each outcome by
entering all beverage variables into the same model. We also
collapsed intake of artificially-sweetened beverage (carbonated and
non-carbonated) to assess the full effect of the sweeteners. Since
the same frequency number could be obtained across two different
individual intake categories we ended up with the following
combined categories (‘never to ,1serv/week’, ‘,1serv/week’,
‘,1serv/week to weekly’, ‘weekly to .=1serv/day’).
All tests were two-sided and statistical significance was
considered at P,0.05. The analyses were performed using the
Statistical Analyses System software (release 9.2; SAS Institute,
Cary, NC).
Results
Study Cohort
A total of 60,466 women had information on artificially-
sweetened carbonated beverage intake. Majority of women were
between the ages 21 and 39 years (98%), of higher socioeconomic
position (high level proficiencies: 23%), and nulliparous (53%)
(Table 1). More than 68% of all women reported a prepregnancy
BMI within 18.6–24.9 kg/m2. Nearly 25% of participants
reported having smoked during pregnancy with 12% being daily
smokers. Prevalence of maternal history of asthma and allergies
was 9% and 32% respectively. Among the exposure variables,
intake of sugar-sweetened non-carbonated soft drinks was highest
with 22% consuming .=1 servings/day, followed by artificially-
sweetened non-carbonated soft drinks at 13%.
When comparing women with and without self-reported child
asthma data at 18 months and 7 years we found that, at 18
months, the 45,604 participants (vs. 16,269 non-participants) in
the analyses were of higher sociodemographic status (54% vs.
51%), were multiparous (48% vs. 44%), did not smoke during
pregnancy (76% vs. 72%), and had slightly lower gestational
weight gain (464 vs. 475 g/week). At 7 years, compared to women
without data on current child asthma (N= 22,947), the 38,926
women with data on child asthma were of higher sociodemo-
graphic status (55% vs. 50%), were more like to have a BMI within
18.6–24.9 kg/m2 (70% vs. 65%), exercise (40% vs. 36%), and not
smoke during pregnancy (77% vs. 72%). No differences were
found for maternal age, parental asthma and allergies, or intake of
selected micronutrients during pregnancy.
Exposure Associations
We assessed intake of artificially-sweetened carbonated bever-
ages across age-standardized study participant characteristics
(Table 1). Compared to never consumers, women with daily
intake of artificially-sweetened carbonated soda drinks tended to
be of a skilled and unskilled level proficiency, have lower parity,
and a prepregnancy BMI .=25 kg/m2. They also smoked more
during pregnancy and breastfed ,7 months. They reported lower
energy intake and higher intake of fruit, vegetables, and alcohol,
but lower intake of vitamin E. Trends were similar for artificially-
sweetened non-carbonated beverages.
Table 1. Cont.
Frequency of intake N1 (%)
Never N=40,523%
or means (SD)
,1 serv/week N=7,588%
or means (SD)
Weekly N=9,971%
or means (SD)
.=1 serv/day N=2,383%
or means (SD)
Total vitamin A (RE/day) 60,227 1,500 (24,090) 1,297 (569) 2,125 (50,352) 2,672 (68,549)
Total vitamin D (mg/day) 60,227 8.9 (5.5) 9.2 (5.5) 9.2 (5.6) 8.9 (5.6)
Total vitamin E (a-TE/day) 60,227 16.4 (19.7) 16.3 (19.9) 15.8 (15.6) 15.4 (14.7)
Total selenium (mg/day) 60,227 70.1 (27.9) 72.8 (27.4) 72.6 (26.9) 70.9 (26.6)
Total zinc (mg/day) 60,227 19.6 (7.7) 20.2 (7.7) 20.1 (7.4) 19.7 (7.4)
Values are standardized to the age distribution of the study population.
*Value not age-adjusted.
1Total may be ,N due to missing values.
doi:10.1371/journal.pone.0057261.t001
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Multivariate Analysis
Child asthma at 18 months follow-up. The prevalence of
child asthma was 17% (N=7,628/44,638). At the 18 month
follow-up, only intake of artificially-sweetened non-carbonated soft
drinks were associated with higher risk of self-reported child
asthma diagnosis (.=1serving/day vs. never: 1.23, 95% CI: 1.13,
1.33) (Table 2). No associations were found for sugar-sweetened
beverages (Tables S1–2). Combining intake of artificially-
sweetened beverages generated effect estimates between the two
sub-categories and was strongest for child asthma (.=1serving/
day vs. never: 1.14, 95% CI: 1.00, 1.28) (data not shown).
Ever asthma and current child asthma at the 7 year
follow-up. The prevalence of ever asthma by DNPR was 6%
(2,265/38,258) and 32% (12,153/38,258) by RMPS. About 4%
(1,536/38,149) of children were classified with current asthma.
Both carbonated and non-carbonated artificially-sweetened soft
drinks were associated with a DNPR and RMPS diagnosis
(Tables 2–3). Mothers who drank at least 1 serving of artificially-
sweetened carbonated soft drink serving per day were 1.30 (95%
CI: 1.01, 1.66) times more likely to have a child with an asthma
diagnosis in the DNPR, and 1.13 (95% CI: 0.98, 1.29) times more
likely to have a child RMPS asthma diagnosis. For artificially-
sweetened non-carbonated soft drinks these odds ratios were 1.14
(95% CI: 0.98, 1.34) and 1.15 (95% CI: 1.06, 1.25) for a DNPR
and RMPS asthma diagnosis respectively. No associations were
found between maternal intake of sugar-sweetened beverages and
child asthma (Tables S1–2). Combining artificially-sweetened
beverage intake categories strengthened the associations for RMPS
asthma diagnosis only (weekly to .=1serving/day vs. never to
,1serving/week: 1.20, 95% CI: 1.07, 1.35). We further excluded
the first 3 years of life for the registry diagnoses and found that
results strengthened with the DNPR diagnosis for both artificially-
sweetened carbonated (.=1serving/day vs. never: 1.44, 95% CI:
1.00, 2.09) and non-carbonated (.=1serving/day vs. never: 1.31,
95% CI: 1.03, 1.66) soft drinks.
Ever child allergic rhinitis at the 7 year follow-up. Close
to 5% (1,855/37,971) of mothers reported an ever child allergic
rhinitis doctor diagnosis on the 7 year questionnaire. Artificially-
sweetened carbonated beverages were directly related to ever
allergic rhinitis (.=1serving/day vs. never: 1.31, 95% CI: 0.98,
1.74) (Table 4). No associations were found for the other types of
beverages (Tables S3). Combining the artificially-sweetened
beverage intake generated results in between the carbonated and
non-carbonated intake categories (.=1serving/day vs. never:
1.11, 95% CI: 0.86, 1.43).
Sensitivity Analyses
The difference between crude and adjusted effect estimates was
primarily accounted for by maternal prepregnancy BMI, socio-
economic position, and breastfeeding duration. However, most
examined covariates were weak confounders and rarely accounted
for more than 10% change in the effect estimates. We further
adjusted the models for other foods and nutrient intake; however,
this did not change the results. When sugar- and artificially-
sweetened beverages were mutually adjusted for, some associations
weakened (e.g. artificially-sweetened carbonated beverages and
child asthma at 18 months), while others strengthened (e.g.
artificially-sweetened carbonated beverages and ever allergic
rhinitis), but the general direction of the associations and the
conclusions did not change. The most notable change was a
strengthening of the effect estimate for artificially-sweetened
carbonated beverages and ever allergic rhinitis (.=1serving/
day vs. never: 1.42, 95% CI: 1.05, 1.91). Further adjustment for
other potential confounders of child asthma and allergies (mode of
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delivery, pets at home, exposure do smoking during infancy,
daycare attendance during infancy, and use of antibiotics and
paracetamol during pregnancy and child use of antibiotics at 6
months as suggested in a recent review by Nurmatov et al [36]) did
not alter the effect estimates. For example, effect estimates for
artificially-sweetened carbonated beverages and asthma at 18
months were 1.07 (95% CI: 0.93, 1.24) (vs. 1.10, 95% CI: 0.95,
1.27) and for artificially-sweetened carbonated beverages and
asthma at 7 years 1.17 (95% CI: 0.87, 1.59) (vs. 1.18, 95% CI:
0.87, 1.59). This analysis was performed to examine the stability of
the estimates but we are cautious about adding these seven
covariates, some of which are conditioning on future conditions,
since we might be imposing overadjustment and bias in our
analyses [37,38].
Based on a previous study from our cohort [16] where we found
a direct association between low-fat yoghurt intake, and asthma
and allergic rhinitis, we examined the relation between intake of
artificially-sweetened beverages and low-fat yoghurt. The strongest
Spearman correlation was with low-fat yoghurt with fruit
(r = 0.07–0.09, P,0.0001) for both carbonated and non-carbon-
ated beverages. When we adjusted for low-fat yoghurt with fruit,
there was no change in effect estimates.
To exclude the possibility that our results were mediated by
preterm birth [30], we restricted the analyses to term births (.37
and ,=42 weeks of gestation), which did not substantially alter
the results. The results for artificially-sweetened carbonated
beverages and self-reported allergic rhinitis strengthened (.=1
serving/day vs. never: 1.44, 95% CI: 1.07, 1.94 vs. 1.31, 95% CI:
0.98, 1.74), while the association between artificially-sweetened
non-carbonated beverages and asthma diagnosis by DNPR
weakened (.=1 serving/day vs. never: 1.06, 95% CI: 0.89,
1.27 vs. 1.14, 95% CI: 0.98, 1.34).
Discussion
In our prospective study of the relation between maternal intake
of artificially-sweetened beverages during pregnancy and devel-
opment of child allergic disease, we found that artificially-
sweetened beverages moderately increased risk of asthma and
allergic rhinitis both in early and later childhood. These results
appeared stronger for carbonated beverages. We did not find
similar results for sugar-sweetened beverages, suggesting that
artificial sweeteners, rather than other additives and aromatic
compounds in soft drinks, may play a role in the development of
allergic diseases.
Little is currently know about artificial sweeteners in relation to
allergic disease development. Artificial sweeteners, and particularly
aspartame, have, however, been studied more broadly in the
context of inflammation [18–20]. One study examined the effect
of aspartame on oxidation in mice brain and liver and found an
increase in tumour-necrosis factor-a and lipid peroxidation in the
brain, while reducing glutathione [18]. Another study in zebra fish
found increased infiltration of inflammatory cells and production
of radical oxygen species in the liver and brain after exposure to
aspartame [19]. In contrast, they did not find anti-inflammatory
properties of aspartame, but found that it did reduce mechanical
allodynia in arthritic rats [20]. Aspartame has also been implicated
in alleviation of autoimmune disease [20,39]. One early study
examined aspartame in relation to allergic activity, specifically the
ability of aspartame to generate ‘allergic’ reactions by inducing
histamine release from mast cells and basophils by a pharmaco-
logical mechanism or by an IgE-dependent process of mast cell
activation [21]. The authors found that aspartame did not act as a
direct mast cell secretagogue, and did not cause degranulation of
cultured mouse mast cells or human basophils in vitro. Aspartame
did decrease antigen-induced histamine release from cultured
mouse mast cells after long-term exposure only. The authors could
not fully explain the origin of this effect but speculated that by
increasing mast cell proliferation, it made mast cells less responsive
to anaphylactic stimulation.
Among human studies, a randomized, double-blind, cross-over
trial among patients with a history of headaches did not find any
difference in histamine levels according to aspartame exposure
[40]. Aspartame has also shown not to cause allergic reaction in
adults when compared to placebo in randomized, double-blinded
studies administering aspartame doses at one time point [24,25]. A
number of smaller studies have shown improvement in dermatitis
with aspartame avoidance [22,23,41]. No human study has
specifically investigated the relation between artificial sweeteners
and the prevention of allergic disease; and it is unclear whether
results from animal experimental and in vitro studies can be
transposed to the human condition in pregnancy. Furthermore,
while majority of these studies involved aspartame; other artificial
sweeteners, such as acesulfame-K, sucralose, or saccharine, need
to be considered as potential active agents. Soft drinks often
contain a mixture of different sweeteners. The predominant
sweeteners in soft drinks appearing on the Danish market are
aspartame and acesulfame-K [26]. Their average concentration is
approximately 2–3-fold higher in carbonated versus noncarbo-
nated soft drinks, which is why we examined them separately. This
could explain the slightly stronger effect size we found for
carbonated soft drink, and furthermore suggests that less
frequently used sweeteners found in non-carbonated beverages,
such as cyclamate and saccharine [26], may not be associated with
allergic disease outcomes. We were not, however, able to
distinguish between intake of specific artificial sweeteners.
It is possible that other additives may account for the observed
findings. The role of food additives in allergic disease is well
known. However, as these are rare events, establishing a causal
link is complex and most of the current knowledge is based on case
reports [42]. As food additives may cause allergic reaction,
exposing subjects to a group of food additives, including
sweeteners, has been recommended in screening for food allergy
[43]. The word ‘‘food additives’’ covers a broad range of
chemically unrelated substances and this approach highlights the
general absence of mechanistic insight for several suspected
allergens.
There were several strengths to our study. These included
examining detailed dietary data collected in pregnancy in a large,
prospective study in relation to several allergic outcomes. We used
outcomes both in early and later childhood in order to differentiate
potential etiologically pathways between outcomes in infancy that
may later resolve and later outcomes that are more likely to
capture clinically relevant asthma and allergic rhinitis. Further-
more, we took advantage of both registry-based and self-reported
outcome assessment. These allowed us to better identify clinical
asthma in the patient registry, particularly after exclusion of early
registry diagnoses, an outcome that may not be as well reported by
questionnaire. The previous paper comparing different assessment
methods of asthma in the DNBC [44] indicated higher specificities
(but lower sensitivities) for the registry based outcomes. If the
registries are more likely to capture the true asthma cases, while
the self-reported outcomes represent a less valid outcome, then this
could explain why we observe associations mainly for the registry
based outcomes. In further analysis we found that the results
strengthened somewhat for ever asthma diagnosed during
inpatient visits, suggesting that disease severity may be an
important mediating factor. Questionnaires may be better for
Artificial Sweeteners in Pregnancy and Asthma Risk
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assessing outcomes such as allergic rhinitis as these are less likely to
end up in registries due to more moderate symptom manifestation
and more prevalent use of over-the-counter medication. Self-
reported asthma may capture mild to moderate disease and can be
used for more direct comparison with other studies using the
International Study of Asthma and Allergies in Childhood
questionnaire.
We found that results differed by outcome with early life
outcomes being associated with artificially-sweetened non-carbon-
ated beverages and registry outcomes more strongly associated
with higher intake of artificially-sweetened carbonated beverages.
This suggests that different sweeteners or other additives may be
accounting for some of the relations. Other plausible explanations
include a difference in timing of outcome or etiological pathways.
For example, the latter may be more governed by T helper (Th) 2
mechanisms while the former by a mixture of Th1- and Th2-
driven pathways [45,46]. As mentioned in the results section, our
results strengthened somewhat after we excluded the first 3 years
of diagnoses from the hospital registry, influence of artificial
sweeteners on pathways in early vs. later childhood may be
different. In an attempt to limit residual confounding, in our
statistical models we adjusted for numerous covariates covering
anthropometry, lifestyle, breastfeeding and familial history of
asthma and other known predictors of asthma. However, we may
have failed to identify all relevant confounders and thus our
findings may be due to residual confounding by unmeasured or
unidentified covariates.
Our study was limited primarily by self-reported assessment of
diet and outcomes. Although there is always some concern with
misclassification when using FFQs for dietary assessment, we
expect it to have differentiated well between low and high
beverage consumers. We therefore expect any misclassification to
have been non-differential and therefore underestimated the true
effect estimates. Furthermore, due to the complex mixtures used in
different beverages we cannot quantify accurately the amount
consumed of individual sweeteners from soft drinks. This may lead
to less precise estimation of effect size and contribute to divergent
conclusions when comparing the results for carbonated and non-
carbonated beverages. Our definition of current asthma has shown
high agreement among cases (.60%) and non-cases (.90%) in a
recent study from our cohort [44] when compared to the DNPR;
yet, the results for the self-reported outcome did not track those of
the registry asthma diagnoses. This could have been due to failure
to capture clinically-relevant asthma. Finally, potential for
selection bias is plausible in a longitudinal study with loss to
follow-up. When we compared participants of this study with non-
participants, participants tended to display healthier life-style
habits. We do however not believe these differences to be large
enough to change our findings.
To conclude, our results from a large prospective cohort study
are indicative of a weak to moderate association between
consumption of artificially-sweetened beverages during pregnancy
and offspring risk of asthma and allergic rhinitis. While this could
be due to residual confounding, we hypothesize that artificial
sweeteners may be the plausible causal agent since no similar
associations were found for sugar-sweetened beverages. We do not
claim our results to be affirmative, but rather they are suggestive
and hypothesis generating. These findings need to be further
explored at a mechanistic level and examined with more detailed
assessment of exposure to artificial sweeteners.
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